New drug may slow Alzheimer's decline, which is faster in women than men
Women suffering from Alzheimer's may face faster mental declines than men with the disease, according to a new study. Researchers still don't know why this is the case. Women are also twice as likely as men to develop the incurable disease.
"Our findings suggest that men and women at risk for Alzheimer's may be having two very different experiences," says lead author Katherine Amy Line at Duke University Medical Center.
In related news, an experimental new drug has been shown to slow the progression of Alzheimer's. Researchers are excited by the results of the early trial, which suggest the drug, solanezumab, acts on the disease process itself and not just on the symptoms. If this finding is confirmed in another trial, solanezumab will be the first drug capable of slowing Alzheimer's progression.
Facts about Alzheimer's:
Alzheimer's disease affects roughly 44 million people around the world.
Dementia and Alzheimer's are not interchangeable, but Alzheimer's accounts for 60%-70% of cases of dementia.
Cover image: Independent